Home › Boston Biomedical Announces Clinical Data Presentation Of Its Cancer Stem Cell Inhibitor Programs
 

Keywords :   


Boston Biomedical Announces Clinical Data Presentation Of Its Cancer Stem Cell Inhibitor Programs

2014-06-16 19:56:43| Logistics - Topix.net

Clinical data were presented for BBI608 and BBI503, novel agents targeting cancer stem cells that have been developed by the company.

Tags: data cell programs presentation

Category:Transportation and Logistics

Latest from this category

All news
01.06Atlantic Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
01.06Atlantic Tropical Weather Outlook
31.05Eastern North Pacific Tropical Weather Outlook
31.05Atlantic Tropical Weather Outlook
31.05Eastern North Pacific Tropical Weather Outlook
31.05Atlantic Tropical Weather Outlook
Transportation and Logistics »
01.06Succession Planning
01.06Weekly Recap: AkzoNobel, PPG, Sherwin-Williams Top This Weeks Stories
01.06Atlantic Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
01.06Eastern North Pacific Tropical Weather Outlook
01.06Atlantic Tropical Weather Outlook
31.05Vytelle expands to Melbourne, Australia with its 21st global bovine IVF lab
31.05USDA celebrates 100 years of agriculture innovation
More »